0 Avaliações

ID

17655

Descrição

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Prevention and Treatment of Skin, Hair and Nail Reactions Due to Study Drug Administration

Link

https://clinicaltrials.gov/ct2/show/NCT00373425

Palavras-chave

  1. 01/08/2016 01/08/2016 -
  2. 27/09/2016 27/09/2016 -
Transferido a

27 de setembro de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    Prevention and Treatment of Skin, Hair and Nail Reactions, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

    Prevention and Treatment of Skin, Hair and Nail Reactions Due to Study Drug Administration, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

    Prevention and Treatment of Skin, Hair and Nail Reactions
    Descrição

    Prevention and Treatment of Skin, Hair and Nail Reactions

    Interventions used to prevent and treat skin, hair and nail reactions: None
    Descrição

    Prevention and Treatment of Skin, Hair and Nail Reactions Due to Study Drug Administration

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0087111 (Therapeutic procedure)
    SNOMED
    277132007
    LOINC
    LP21090-3
    UMLS CUI [1,2]
    C0221743 (Skin reaction)
    SNOMED
    251348006
    UMLS CUI [2,1]
    C0087111 (Therapeutic procedure)
    SNOMED
    277132007
    LOINC
    LP21090-3
    UMLS CUI [2,2]
    C0018500 (Hair Diseases)
    SNOMED
    279425004
    UMLS CUI [3,1]
    C0087111 (Therapeutic procedure)
    SNOMED
    277132007
    LOINC
    LP21090-3
    UMLS CUI [3,2]
    C0234909 (Nail changes)
    SNOMED
    416596008
    Prevention and Treatment of Skin, Hair and Nail Reactions Due to Study Drug Administration
    Descrição

    Prevention and Treatment of Skin, Hair and Nail Reactions Due to Study Drug Administration

    Intervention (Use generic name when possible)
    Descrição

    Record all topical creams, gels, oral or IV medications, and/or other interventions used to prevent and treat skin, hair and nail reactions (includes rash, skin fissures, nail and hair changes, etc) due to study drug administration. Moisturizers and sunscreens used to prevent and treat skin reactions should be recorded on the Moisturizers and Sunscreens CRF page.

    Tipo de dados

    text

    Alias
    UMLS CUI [1,1]
    C0087111 (Therapeutic procedure)
    SNOMED
    277132007
    LOINC
    LP21090-3
    UMLS CUI [1,2]
    C0221743 (Skin reaction)
    SNOMED
    251348006
    UMLS CUI [2,1]
    C0087111 (Therapeutic procedure)
    SNOMED
    277132007
    LOINC
    LP21090-3
    UMLS CUI [2,2]
    C0018500 (Hair Diseases)
    SNOMED
    279425004
    UMLS CUI [3,1]
    C0087111 (Therapeutic procedure)
    SNOMED
    277132007
    LOINC
    LP21090-3
    UMLS CUI [3,2]
    C0234909 (Nail changes)
    SNOMED
    416596008
    Prophylaxis
    Descrição

    Indication Prophylaxis

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C3146298 (Indication)
    UMLS CUI [1,2]
    C0199176 (Prophylactic treatment)
    SNOMED
    360271000
    Route
    Descrição

    Drug Administration Route

    Tipo de dados

    integer

    Alias
    UMLS CUI [1]
    C0013153 (Drug Administration Routes)
    SNOMED
    410675002
    LOINC
    LP40261-7
    If other, please specify
    Descrição

    Drug Administration Route

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C0013153 (Drug Administration Routes)
    SNOMED
    410675002
    LOINC
    LP40261-7
    Indication
    Descrição

    Specific Indication should be reported on the Adverse Event (Including Baseline Signs/Symptoms) CRF page, unless the intervention was given as a prophylaxis.

    Tipo de dados

    integer

    Alias
    UMLS CUI [1]
    C3146298 (Indication)
    If other, please specify
    Descrição

    Indication

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C3146298 (Indication)
    Date Started
    Descrição

    Date Started

    Tipo de dados

    date

    Alias
    UMLS CUI [1]
    C3173309 (Date treatment or therapy started)
    LOINC
    LP262646-5
    Date Stopped
    Descrição

    Date Stopped

    Tipo de dados

    date

    Alias
    UMLS CUI [1]
    C1531784 (Date treatment stopped)
    SNOMED
    413947000
    Date stopped: Post treatment
    Descrição

    Date Stopped

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1531784 (Date treatment stopped)
    SNOMED
    413947000

    Similar models

    Prevention and Treatment of Skin, Hair and Nail Reactions Due to Study Drug Administration, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    Prevention and Treatment of Skin, Hair and Nail Reactions
    Prevention and Treatment of Skin, Hair and Nail Reactions Due to Study Drug Administration
    Item
    Interventions used to prevent and treat skin, hair and nail reactions: None
    boolean
    C0087111 (UMLS CUI [1,1])
    C0221743 (UMLS CUI [1,2])
    C0087111 (UMLS CUI [2,1])
    C0018500 (UMLS CUI [2,2])
    C0087111 (UMLS CUI [3,1])
    C0234909 (UMLS CUI [3,2])
    Item Group
    Prevention and Treatment of Skin, Hair and Nail Reactions Due to Study Drug Administration
    Intervention
    Item
    Intervention (Use generic name when possible)
    text
    C0087111 (UMLS CUI [1,1])
    C0221743 (UMLS CUI [1,2])
    C0087111 (UMLS CUI [2,1])
    C0018500 (UMLS CUI [2,2])
    C0087111 (UMLS CUI [3,1])
    C0234909 (UMLS CUI [3,2])
    Indication Prophylaxis
    Item
    Prophylaxis
    boolean
    C3146298 (UMLS CUI [1,1])
    C0199176 (UMLS CUI [1,2])
    Item
    Route
    integer
    C0013153 (UMLS CUI [1])
    Code List
    Route
    CL Item
    Topical (1)
    CL Item
    Oral (2)
    CL Item
    IV (3)
    CL Item
    Procedure (4)
    CL Item
    Other (specify) (5)
    Drug Administration Route
    Item
    If other, please specify
    text
    C0013153 (UMLS CUI [1])
    Item
    Indication
    integer
    C3146298 (UMLS CUI [1])
    Code List
    Indication
    CL Item
    Skin Reaction (1)
    CL Item
    Hair Changes (2)
    CL Item
    Nail Changes (3)
    CL Item
    Other (specify) (4)
    Indication
    Item
    If other, please specify
    text
    C3146298 (UMLS CUI [1])
    Date Started
    Item
    Date Started
    date
    C3173309 (UMLS CUI [1])
    Date Stopped
    Item
    Date Stopped
    date
    C1531784 (UMLS CUI [1])
    Date Stopped
    Item
    Date stopped: Post treatment
    boolean
    C1531784 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial